Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Lymphoma × omipalisib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Uveal Melanoma 1 Neurofibromatosis 1 1 Neoplasms 1 Melanoma 1 Lymphoma 1 Leukemia, Myelomonocytic, Juvenile 1 Carcinoma, Non-Small-Cell Lung 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 382 Rituximab 329 Etoposide 190 Vincristine 177 Filgrastim 173 Doxorubicin 168 Prednisone 144 Radiotherapy 137 Cytarabine 134 fludarabine phosphate 122 Methotrexate 112 Melphalan 111 Peripheral Blood Stem Cell Transplantation 106 fludarabine 102 Busulfan 84 Dexamethasone 74 Carmustine 64 Granulocyte Colony-Stimulating Factor 61 Tacrolimus 58 Gemcitabine 56 Whole-Body Irradiation 55 Mycophenolic Acid 55 Bendamustine Hydrochloride 55 Antilymphocyte Serum 55 Cyclosporine 51 Lenalidomide 50 Ifosfamide 50 Bortezomib 49 Methylprednisolone 42 Leucovorin 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00972686 2017-05-09

FTIH

GlaxoSmithKline

Phase 1 Completed

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡